Caring for the Ages
July 31, 2023
Showing 1471 - 1480 of 8300 results
Caring for the Ages
January 30, 2017
Celecoxib: Cardiovascular Risk No Worse Than That of Nonselective NSAIDs
JAMDA
May 17, 2022
Centenarians From Long-Term Care Facilities and COVID-19–Relevant Hospital Admissions
Caring for the Ages
March 2, 2015
Centers Study Innovative Ways to Support Aging in Place
JAMDA
February 23, 2017
Central Nervous System (CNS) Medication Burden & Risk of Serious Falls in Older Nursing Home Residents
JAMDA
June 14, 2025
Central Nervous System Polypharmacy Among People Living With Dementia
The Centers for Medicare and Medicaid Services Polypharmacy-CNS (Poly-CNS) quality metric identifies individuals taking multiple medications with central nervous system side effects. The Poly-CNS measure may reduce risky prescribing for persons living with dementia (PLWD).
JAMDA
March 24, 2016
Central Nervous System-Acting Medicines and Risk of Hospital Admission for Confusion, Delirium, or Dementia
Most studies assessing the effect of central nervous system (CNS)-acting medicines on cognitive disturbances have focused on the use of individual medicines. The impact on cognitive function when another CNS-acting medicine is added to a patient's treatment regimen is not well known.
JAMDA
August 30, 2021
Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in Dementia
To investigate the associations between central anticholinergic burden and mortality, hospitalization, and cognitive impairment in people with dementia prescribed anticholinergic drugs for urinary symptoms.
JAMDA
February 26, 2019
Cerebral Amyloid Angiopathy Limits Treatment of Stroke
Basic Page